CA2124455C - Indole derivatives, process for producing the same and medicinal uses of the same - Google Patents

Indole derivatives, process for producing the same and medicinal uses of the same Download PDF

Info

Publication number
CA2124455C
CA2124455C CA002124455A CA2124455A CA2124455C CA 2124455 C CA2124455 C CA 2124455C CA 002124455 A CA002124455 A CA 002124455A CA 2124455 A CA2124455 A CA 2124455A CA 2124455 C CA2124455 C CA 2124455C
Authority
CA
Canada
Prior art keywords
epoxy
indolomorphinan
didehydro
dihydroxy
cyclopropylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002124455A
Other languages
English (en)
French (fr)
Other versions
CA2124455A1 (en
Inventor
Hiroshi Nagase
Akira Mizusuna
Koji Kawai
Izumi Nakatani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Publication of CA2124455A1 publication Critical patent/CA2124455A1/en
Application granted granted Critical
Publication of CA2124455C publication Critical patent/CA2124455C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
CA002124455A 1992-09-29 1993-09-29 Indole derivatives, process for producing the same and medicinal uses of the same Expired - Fee Related CA2124455C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25984192 1992-09-29
JP259841/92 1992-09-29
PCT/JP1993/001388 WO1994007896A1 (fr) 1992-09-29 1993-09-29 Derive indole, procede pour sa fabrication, et son usage medicinal

Publications (2)

Publication Number Publication Date
CA2124455A1 CA2124455A1 (en) 1994-04-14
CA2124455C true CA2124455C (en) 2004-09-14

Family

ID=17339733

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002124455A Expired - Fee Related CA2124455C (en) 1992-09-29 1993-09-29 Indole derivatives, process for producing the same and medicinal uses of the same

Country Status (14)

Country Link
US (2) US6087369A (2)
EP (1) EP0614898B1 (2)
JP (1) JP3605825B2 (2)
KR (1) KR100301093B1 (2)
CN (1) CN1043766C (2)
AT (1) ATE239732T1 (2)
AU (1) AU672033B2 (2)
CA (1) CA2124455C (2)
DE (1) DE69332945T2 (2)
ES (1) ES2199220T3 (2)
FI (1) FI942499A7 (2)
NO (1) NO941977L (2)
TW (1) TW271440B (2)
WO (1) WO1994007896A1 (2)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100301093B1 (ko) * 1992-09-29 2001-10-22 히라이 가쯔히꼬 인돌유도체,그제조방법및그의약용도
US5464841A (en) * 1993-11-08 1995-11-07 Univ Minnesota Use of delta opioid receptor antagonists to treat immunoregulatory disorders
SE9401727D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds I
SE9401728D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds II
US5578725A (en) * 1995-01-30 1996-11-26 Regents Of The University Of Minnesota Delta opioid receptor antagonists
ES2197953T3 (es) * 1995-09-26 2004-01-16 Toray Industries, Inc. Derivados de indol y aplicaciones medicas de los mismos.
US5994327A (en) * 1995-11-17 1999-11-30 Astra Ab Process for the preparation of morphinans
BR9707136A (pt) * 1996-01-10 1999-08-31 Smithkline Beecham Spa Derivados morfinóides condesados em heterociclo (ii)
AU739367B2 (en) * 1997-01-16 2001-10-11 Toray Industries, Inc. Indolomorphinan derivative and agent for curing and preventing cerebral disorder
WO1998043977A1 (en) * 1997-03-31 1998-10-08 Toray Industries, Inc. Quinolinomorphinane derivatives and medicinal use thereof
US5986141A (en) * 1998-09-29 1999-11-16 Eastman Chemical Company Process for the production of cyclopropanemethylamine
CN1204139C (zh) * 1999-08-24 2005-06-01 东丽株式会社 神经性疼痛治疗剂
US8205237B2 (en) 2000-09-14 2012-06-19 Cox Ingemar J Identifying works, using a sub-linear time search, such as an approximate nearest neighbor search, for initiating a work-based action, such as an action on the internet
US7232829B2 (en) 2001-04-06 2007-06-19 Regents Of The University Of Minnesota Therapeutic compounds and methods
US6858619B2 (en) 2001-05-04 2005-02-22 Amgen Inc. Fused heterocyclic compounds
US6809104B2 (en) 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
EP1517689A2 (en) * 2002-01-25 2005-03-30 Regents Of The University Of Minnesota Selective analgesic agents
CN101134757A (zh) 2002-11-06 2008-03-05 安姆根有限公司 稠合杂环化合物
EP1595541A1 (en) * 2004-05-12 2005-11-16 Alcasynn Pharmaceuticals Gmbh Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
ES2784690T3 (es) 2013-12-05 2020-09-29 Univ Bath Nuevos compuestos opioides y sus usos

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3631829A1 (de) * 1986-09-19 1988-07-28 Hoechst Ag Klonierung und verwendung des transaminase gens-tyrb
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
JP2906654B2 (ja) * 1989-11-28 1999-06-21 東レ株式会社 免疫抑制剤及びその製造方法
JPH04342529A (ja) * 1991-05-21 1992-11-30 Toray Ind Inc 抗アレルギー剤
US5354863A (en) * 1992-01-21 1994-10-11 G. D. Searle & Co. Opioid agonist compounds
US5225417A (en) * 1992-01-21 1993-07-06 G. D. Searle & Co. Opioid agonist compounds
US5352680A (en) * 1992-07-15 1994-10-04 Regents Of The University Of Minnesota Delta opioid receptor antagonists to block opioid agonist tolerance and dependence
KR100301093B1 (ko) * 1992-09-29 2001-10-22 히라이 가쯔히꼬 인돌유도체,그제조방법및그의약용도
US5457208A (en) * 1993-06-21 1995-10-10 Regents Of The University Of Minnesota Kappa opioid receptor antagonists
ES2197953T3 (es) * 1995-09-26 2004-01-16 Toray Industries, Inc. Derivados de indol y aplicaciones medicas de los mismos.

Also Published As

Publication number Publication date
EP0614898A1 (en) 1994-09-14
DE69332945T2 (de) 2004-05-19
US6291470B1 (en) 2001-09-18
FI942499L (fi) 1994-07-27
NO941977D0 (no) 1994-05-27
KR100301093B1 (ko) 2001-10-22
EP0614898A4 (en) 1994-10-12
AU4834193A (en) 1994-04-26
CA2124455A1 (en) 1994-04-14
FI942499A7 (fi) 1994-07-27
ATE239732T1 (de) 2003-05-15
CN1043766C (zh) 1999-06-23
ES2199220T3 (es) 2004-02-16
CN1092425A (zh) 1994-09-21
DE69332945D1 (de) 2003-06-12
NO941977L (no) 1994-07-29
WO1994007896A1 (fr) 1994-04-14
FI942499A0 (fi) 1994-05-27
EP0614898B1 (en) 2003-05-07
JP3605825B2 (ja) 2004-12-22
US6087369A (en) 2000-07-11
AU672033B2 (en) 1996-09-19
TW271440B (2) 1996-03-01

Similar Documents

Publication Publication Date Title
CA2124455C (en) Indole derivatives, process for producing the same and medicinal uses of the same
US5770605A (en) Method for treating leukemia with a hexa-cyclic compound
AU652728B2 (en) Camptothecin analogs as potent inhibitors of human colorectal cancer
US5180722A (en) 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
KR100191193B1 (ko) 6환 화합물
EP0418099A2 (en) 10, 11-Methylenedioxy-20 (RS) camptothecin and 10, 11-methylenedioxy-20 (S) - camptothecin analog
JPWO1994007896A1 (ja) インドール誘導体，その製造方法およびその医薬用途
CZ304465B6 (cs) Kamptothecinové deriváty mající protinádorové účinky
JP2025515988A (ja) カンプトテシン化合物、その調製方法及びその使用
CA3025710A1 (en) Phenyl propanamide derivative, and manufacturing method and pharmaceutical application thereof
US5340817A (en) Method of treating tumors with anti-tumor effective camptothecin compounds
EP3917926B1 (en) Imidazoquinoline amine derivatives, pharmaceutical composition, use thereof
BRPI0611313A2 (pt) compostos de espiro heterocìclicos
WO2021071803A1 (en) Aryl heterobicyclic compounds as kv1.3 potassium shaker channel blockers
US9073920B2 (en) Substituted dibenzonaphthyridines, pharmaceutical uses thereof and processes therfor
US5852030A (en) Indole derivatives, process for producing the same and medicinal uses of the same
WO2012007619A1 (es) Proceso de obtención de derivados solubles en agua de 20(s)camptotecina como agentes antitumorales
WO1991004260A2 (en) 10,11-methylenedioxy-20(rs)-camptothecin and 10,11-methylenedioxy-20(s)-camptothecin analogs
ES2217533T3 (es) Derivados de indolomorfinano y medicamentos/preventivos para transtornos cerebrales.
JPWO1998031684A1 (ja) インドロモルヒナン誘導体および脳障害治療・予防剤
CA2493090C (fr) Nouveaux derives de benzo[b]chromeno-naphthyridin-7-one et de pyrano[2'3':7,8]quino[2,3-b]quinoxalin-7-one, leur procede de preparation et les compositions pharmaceutiques qui lescontiennent
JP2001011078A (ja) ７−オキソ−２，３，７，１４−テトラヒドロ−１Ｈ−ベンゾ〔ｂ〕ピラノ〔３，２−ｈ〕アクリジンカルボキシラートの新しい化合物、これらの製造方法及びこれらを含む医薬組成物
EP4678634A1 (en) Androgen receptor modulators and uses thereof
CN116535424A (zh) 作为malt1抑制剂的三并环化合物及其药物组合物和应用
WO2025162253A1 (zh) 螺环类化合物、包含其的药物组合物及其用途

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed